Bethany Young Holt, PhD, MPH
Bethany Young Holt, PhD, MPH is the Founder and Executive Director of CAMI Health, an organization dedicated to advancing the health of women and girls worldwide. She is also the Co-Founder and Director of the Initiative for MPTs (IMPT), and a Principal Investigator (PI) at the Public Health Institute.
Dr. Young Holt has over 25 years of experience working on health prevention programs and research projects in the United States, Africa, and South Pacific. She has collaborated with multidisciplinary teams of researchers, including clinicians, product developers, socio-behavioral and market researchers, as well as funders, advocates, and community groups to build and advance the field of multipurpose prevention technologies (MPTs)—an innovative class of products that deliver varied combinations of HIV prevention, other STI prevention, and contraception.
Dr. Young Holt has published in peer-reviewed academic journals and in the popular press, including the New York Times, Vogue, and New Women Magazine. Prior to founding CAMI Health in 2001, her experience includes traineeships at the National Cancer Institute, the Centers for Disease Control and Prevention, and the Institute Pasteur in Dakar, Senegal. She has also been a lecturer and research epidemiologist at the School of Public Health, University of California, Berkeley.
Dr. Young Holt holds a PhD in Epidemiology, an MPH in Maternal and Child Health from University of California, Berkeley, and a BS in Biology from the College of Wooster.
Advancing the Development and Availability of MPT Products for Those at Highest Unmet Need Around the Globe
The overall goal of this activity is to support the Initiative for Multipurpose Prevention Technologies (IMPT) Secretariat in its role as the product-neutral coordinator of the MPT field. The IMPT advances the comprehensive sexual and reproductive health of women and girls worldwide by fostering the progress of the MPT field. Given the limited resource landscape and technical complexities that situate the MPT field, the IMPT—with CAMI Health as Secretariat—functions as a product-neutral learning network for the field by facilitating interdisciplinary collaborations, managing MPT-related knowledge, and developing field-wide recommendations.
As Secretariat, CAMI Health specifically aims to: facilitate the strategic planning process for the IMPT and MPT field; optimize collaboration among supporting agencies to support efficient investment decisions; serve as a knowledge manager; facilitate collaboration and information sharing within the IMPT network; and advance a common technical agenda for the MPT field, including conducting gap analyses around priority issues and developing objective tools and guidance for MPT development.
Health Literacy around MPTs and Simultaneous Prevention of Unintended Pregnancies and STIs
CAMI Health believes that the availability of desirable methods that deliver an array of prevention combinations will improve the lives of women and their families worldwide. Our primary project is managing an international network of experts to advance the field of MPTs as Secretariat for the Initiative for Multipurpose Prevention Technologies (IMPT). The IMPT advances the development of MPTs to address the interlinked risks of unintended pregnancy and STIs including HIV. It is the central body that funders, developers, and others rely on for objective technical guidance and strategic planning to ensure that MPTs in development are not only clinically efficacious and safe, but also desired, acceptable, and accessible to women and girls worldwide. As a learning network, the IMPT houses MPT relevant news and materials in its comprehensive resource center database to support MPT research, advocacy, and education.